Get Real Time Here
| Open16.550 | Close- |
| Vol / Avg.155.414K / 686.019K | Mkt Cap1.007B |
| Day Range16.510 - 17.010 | 52 Wk Range14.470 - 36.640 |
Pliant Therapeutics Stock (NASDAQ:PLRX), Quotes and News Summary
Pliant Therapeutics Stock (NASDAQ: PLRX) stock price, news, charts, stock research, profile.
| Open16.550 | Close- |
| Vol / Avg.155.414K / 686.019K | Mkt Cap1.007B |
| Day Range16.510 - 17.010 | 52 Wk Range14.470 - 36.640 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.710 | -0.700 | 0.0100 | ||||
| REV | 880.000K | 248.000K | -632.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-27 | HC Wainwright & Co. | Ed Arce | Maintains | BuyBuy | Raises | 50.00 | 52.00 |
| 2023-09-27 | Needham | Joseph Stringer | Reiterates | BuyBuy | Maintains | - | 45.00 |
| 2023-09-15 | Needham | Joseph Stringer | Reiterates | BuyBuy | Maintains | - | 45.00 |
| 2023-08-29 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 50.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PLRX | Pliant Therapeutics | 2.62% | 1B |
| GHRS | GH Research | -1.62% | 538.4M |
| SUPN | Supernus Pharmaceuticals | -1.39% | 1.5B |
| VRNA | Verona Pharma | -0.18% | 1.3B |
| WVE | WAVE Life Sciences | -3.83% | 546.4M |
How do I buy Pliant Therapeutics (PLRX) stock?
You can purchase shares of Pliant Therapeutics (NASDAQ: PLRX) through any online brokerage.
Who are Pliant Therapeutics's (PLRX) competitors?
Other companies in Pliant Therapeutics’s space includes: GH Research (NASDAQ:GHRS), Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE) and CymaBay Therapeutics (NASDAQ:CBAY).
What is the target price for Pliant Therapeutics (PLRX) stock?
The latest price target for Pliant Therapeutics (NASDAQ: PLRX) was reported by HC Wainwright & Co. on Wednesday, September 27, 2023. The analyst firm set a price target for 52.00 expecting PLRX to rise to within 12 months (a possible 208.97% upside). 35 analyst firms have reported ratings in the last year.
Current Stock Price for Pliant Therapeutics (PLRX)?
The stock price for Pliant Therapeutics (NASDAQ: PLRX) is $16.83 last updated Today at September 29, 2023 at 3:30 PM UTC.
Does Pliant Therapeutics (PLRX) pay a dividend?
There is no dividend information for Pliant Therapeutics.
When is Pliant Therapeutics (NASDAQ:PLRX) reporting earnings?
Pliant Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Pliant Therapeutics (PLRX) going to split?
There is no upcoming split for Pliant Therapeutics.
What sector and industry does Pliant Therapeutics (PLRX) operate in?
Pliant Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Pliant Therapeutics Stock (NASDAQ:PLRX), Quotes and News Summary
Pliant Therapeutics Stock (NASDAQ: PLRX) stock price, news, charts, stock research, profile.
| Open16.550 | Close- |
| Vol / Avg.155.414K / 686.019K | Mkt Cap1.007B |
| Day Range16.510 - 17.010 | 52 Wk Range14.470 - 36.640 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.710 | -0.700 | 0.0100 | ||||
| REV | 880.000K | 248.000K | -632.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-27 | HC Wainwright & Co. | Ed Arce | Maintains | BuyBuy | Raises | 50.00 | 52.00 |
| 2023-09-27 | Needham | Joseph Stringer | Reiterates | BuyBuy | Maintains | - | 45.00 |
| 2023-09-15 | Needham | Joseph Stringer | Reiterates | BuyBuy | Maintains | - | 45.00 |
| 2023-08-29 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 50.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PLRX | Pliant Therapeutics | 2.62% | 1B |
| GHRS | GH Research | -1.62% | 538.4M |
| SUPN | Supernus Pharmaceuticals | -1.39% | 1.5B |
| VRNA | Verona Pharma | -0.18% | 1.3B |
| WVE | WAVE Life Sciences | -3.83% | 546.4M |
How do I buy Pliant Therapeutics (PLRX) stock?
You can purchase shares of Pliant Therapeutics (NASDAQ: PLRX) through any online brokerage.
Who are Pliant Therapeutics's (PLRX) competitors?
Other companies in Pliant Therapeutics’s space includes: GH Research (NASDAQ:GHRS), Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE) and CymaBay Therapeutics (NASDAQ:CBAY).
What is the target price for Pliant Therapeutics (PLRX) stock?
The latest price target for Pliant Therapeutics (NASDAQ: PLRX) was reported by HC Wainwright & Co. on Wednesday, September 27, 2023. The analyst firm set a price target for 52.00 expecting PLRX to rise to within 12 months (a possible 208.97% upside). 35 analyst firms have reported ratings in the last year.
Current Stock Price for Pliant Therapeutics (PLRX)?
The stock price for Pliant Therapeutics (NASDAQ: PLRX) is $16.83 last updated Today at September 29, 2023 at 3:30 PM UTC.
Does Pliant Therapeutics (PLRX) pay a dividend?
There is no dividend information for Pliant Therapeutics.
When is Pliant Therapeutics (NASDAQ:PLRX) reporting earnings?
Pliant Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Pliant Therapeutics (PLRX) going to split?
There is no upcoming split for Pliant Therapeutics.
What sector and industry does Pliant Therapeutics (PLRX) operate in?
Pliant Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Pliant Therapeutics Stock (NASDAQ:PLRX), Quotes and News Summary
Pliant Therapeutics Stock (NASDAQ: PLRX) stock price, news, charts, stock research, profile.
| Open16.550 | Close- |
| Vol / Avg.155.414K / 686.019K | Mkt Cap1.007B |
| Day Range16.510 - 17.010 | 52 Wk Range14.470 - 36.640 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.710 | -0.700 | 0.0100 | ||||
| REV | 880.000K | 248.000K | -632.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-27 | HC Wainwright & Co. | Ed Arce | Maintains | BuyBuy | Raises | 50.00 | 52.00 |
| 2023-09-27 | Needham | Joseph Stringer | Reiterates | BuyBuy | Maintains | - | 45.00 |
| 2023-09-15 | Needham | Joseph Stringer | Reiterates | BuyBuy | Maintains | - | 45.00 |
| 2023-08-29 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 50.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PLRX | Pliant Therapeutics | 2.62% | 1B |
| GHRS | GH Research | -1.62% | 538.4M |
| SUPN | Supernus Pharmaceuticals | -1.39% | 1.5B |
| VRNA | Verona Pharma | -0.18% | 1.3B |
| WVE | WAVE Life Sciences | -3.83% | 546.4M |
How do I buy Pliant Therapeutics (PLRX) stock?
You can purchase shares of Pliant Therapeutics (NASDAQ: PLRX) through any online brokerage.
Who are Pliant Therapeutics's (PLRX) competitors?
Other companies in Pliant Therapeutics’s space includes: GH Research (NASDAQ:GHRS), Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE) and CymaBay Therapeutics (NASDAQ:CBAY).
What is the target price for Pliant Therapeutics (PLRX) stock?
The latest price target for Pliant Therapeutics (NASDAQ: PLRX) was reported by HC Wainwright & Co. on Wednesday, September 27, 2023. The analyst firm set a price target for 52.00 expecting PLRX to rise to within 12 months (a possible 208.97% upside). 35 analyst firms have reported ratings in the last year.
Current Stock Price for Pliant Therapeutics (PLRX)?
The stock price for Pliant Therapeutics (NASDAQ: PLRX) is $16.83 last updated Today at September 29, 2023 at 3:30 PM UTC.
Does Pliant Therapeutics (PLRX) pay a dividend?
There is no dividend information for Pliant Therapeutics.
When is Pliant Therapeutics (NASDAQ:PLRX) reporting earnings?
Pliant Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Pliant Therapeutics (PLRX) going to split?
There is no upcoming split for Pliant Therapeutics.
What sector and industry does Pliant Therapeutics (PLRX) operate in?
Pliant Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Pliant Therapeutics Stock (NASDAQ:PLRX), Quotes and News Summary
Pliant Therapeutics Stock (NASDAQ: PLRX) stock price, news, charts, stock research, profile.
| Open16.550 | Close- |
| Vol / Avg.155.414K / 686.019K | Mkt Cap1.007B |
| Day Range16.510 - 17.010 | 52 Wk Range14.470 - 36.640 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.710 | -0.700 | 0.0100 | ||||
| REV | 880.000K | 248.000K | -632.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-27 | HC Wainwright & Co. | Ed Arce | Maintains | BuyBuy | Raises | 50.00 | 52.00 |
| 2023-09-27 | Needham | Joseph Stringer | Reiterates | BuyBuy | Maintains | - | 45.00 |
| 2023-09-15 | Needham | Joseph Stringer | Reiterates | BuyBuy | Maintains | - | 45.00 |
| 2023-08-29 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 50.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PLRX | Pliant Therapeutics | 2.62% | 1B |
| GHRS | GH Research | -1.62% | 538.4M |
| SUPN | Supernus Pharmaceuticals | -1.39% | 1.5B |
| VRNA | Verona Pharma | -0.18% | 1.3B |
| WVE | WAVE Life Sciences | -3.83% | 546.4M |
How do I buy Pliant Therapeutics (PLRX) stock?
You can purchase shares of Pliant Therapeutics (NASDAQ: PLRX) through any online brokerage.
Who are Pliant Therapeutics's (PLRX) competitors?
Other companies in Pliant Therapeutics’s space includes: GH Research (NASDAQ:GHRS), Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE) and CymaBay Therapeutics (NASDAQ:CBAY).
What is the target price for Pliant Therapeutics (PLRX) stock?
The latest price target for Pliant Therapeutics (NASDAQ: PLRX) was reported by HC Wainwright & Co. on Wednesday, September 27, 2023. The analyst firm set a price target for 52.00 expecting PLRX to rise to within 12 months (a possible 208.97% upside). 35 analyst firms have reported ratings in the last year.
Current Stock Price for Pliant Therapeutics (PLRX)?
The stock price for Pliant Therapeutics (NASDAQ: PLRX) is $16.83 last updated Today at September 29, 2023 at 3:30 PM UTC.
Does Pliant Therapeutics (PLRX) pay a dividend?
There is no dividend information for Pliant Therapeutics.
When is Pliant Therapeutics (NASDAQ:PLRX) reporting earnings?
Pliant Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Pliant Therapeutics (PLRX) going to split?
There is no upcoming split for Pliant Therapeutics.
What sector and industry does Pliant Therapeutics (PLRX) operate in?
Pliant Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Pliant Therapeutics Stock (NASDAQ:PLRX), Quotes and News Summary
Pliant Therapeutics Stock (NASDAQ: PLRX) stock price, news, charts, stock research, profile.
| Open16.550 | Close- |
| Vol / Avg.155.414K / 686.019K | Mkt Cap1.007B |
| Day Range16.510 - 17.010 | 52 Wk Range14.470 - 36.640 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.710 | -0.700 | 0.0100 | ||||
| REV | 880.000K | 248.000K | -632.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-27 | HC Wainwright & Co. | Ed Arce | Maintains | BuyBuy | Raises | 50.00 | 52.00 |
| 2023-09-27 | Needham | Joseph Stringer | Reiterates | BuyBuy | Maintains | - | 45.00 |
| 2023-09-15 | Needham | Joseph Stringer | Reiterates | BuyBuy | Maintains | - | 45.00 |
| 2023-08-29 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 50.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PLRX | Pliant Therapeutics | 2.62% | 1B |
| GHRS | GH Research | -1.62% | 538.4M |
| SUPN | Supernus Pharmaceuticals | -1.39% | 1.5B |
| VRNA | Verona Pharma | -0.18% | 1.3B |
| WVE | WAVE Life Sciences | -3.83% | 546.4M |
How do I buy Pliant Therapeutics (PLRX) stock?
You can purchase shares of Pliant Therapeutics (NASDAQ: PLRX) through any online brokerage.
Who are Pliant Therapeutics's (PLRX) competitors?
Other companies in Pliant Therapeutics’s space includes: GH Research (NASDAQ:GHRS), Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE) and CymaBay Therapeutics (NASDAQ:CBAY).
What is the target price for Pliant Therapeutics (PLRX) stock?
The latest price target for Pliant Therapeutics (NASDAQ: PLRX) was reported by HC Wainwright & Co. on Wednesday, September 27, 2023. The analyst firm set a price target for 52.00 expecting PLRX to rise to within 12 months (a possible 208.97% upside). 35 analyst firms have reported ratings in the last year.
Current Stock Price for Pliant Therapeutics (PLRX)?
The stock price for Pliant Therapeutics (NASDAQ: PLRX) is $16.83 last updated Today at September 29, 2023 at 3:30 PM UTC.
Does Pliant Therapeutics (PLRX) pay a dividend?
There is no dividend information for Pliant Therapeutics.
When is Pliant Therapeutics (NASDAQ:PLRX) reporting earnings?
Pliant Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Pliant Therapeutics (PLRX) going to split?
There is no upcoming split for Pliant Therapeutics.
What sector and industry does Pliant Therapeutics (PLRX) operate in?
Pliant Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Pliant Therapeutics Stock (NASDAQ:PLRX), Quotes and News Summary
Pliant Therapeutics Stock (NASDAQ: PLRX) stock price, news, charts, stock research, profile.
| Open16.550 | Close- |
| Vol / Avg.155.414K / 686.019K | Mkt Cap1.007B |
| Day Range16.510 - 17.010 | 52 Wk Range14.470 - 36.640 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.710 | -0.700 | 0.0100 | ||||
| REV | 880.000K | 248.000K | -632.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-27 | HC Wainwright & Co. | Ed Arce | Maintains | BuyBuy | Raises | 50.00 | 52.00 |
| 2023-09-27 | Needham | Joseph Stringer | Reiterates | BuyBuy | Maintains | - | 45.00 |
| 2023-09-15 | Needham | Joseph Stringer | Reiterates | BuyBuy | Maintains | - | 45.00 |
| 2023-08-29 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 50.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PLRX | Pliant Therapeutics | 2.62% | 1B |
| GHRS | GH Research | -1.62% | 538.4M |
| SUPN | Supernus Pharmaceuticals | -1.39% | 1.5B |
| VRNA | Verona Pharma | -0.18% | 1.3B |
| WVE | WAVE Life Sciences | -3.83% | 546.4M |
How do I buy Pliant Therapeutics (PLRX) stock?
You can purchase shares of Pliant Therapeutics (NASDAQ: PLRX) through any online brokerage.
Who are Pliant Therapeutics's (PLRX) competitors?
Other companies in Pliant Therapeutics’s space includes: GH Research (NASDAQ:GHRS), Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE) and CymaBay Therapeutics (NASDAQ:CBAY).
What is the target price for Pliant Therapeutics (PLRX) stock?
The latest price target for Pliant Therapeutics (NASDAQ: PLRX) was reported by HC Wainwright & Co. on Wednesday, September 27, 2023. The analyst firm set a price target for 52.00 expecting PLRX to rise to within 12 months (a possible 208.97% upside). 35 analyst firms have reported ratings in the last year.
Current Stock Price for Pliant Therapeutics (PLRX)?
The stock price for Pliant Therapeutics (NASDAQ: PLRX) is $16.83 last updated Today at September 29, 2023 at 3:30 PM UTC.
Does Pliant Therapeutics (PLRX) pay a dividend?
There is no dividend information for Pliant Therapeutics.
When is Pliant Therapeutics (NASDAQ:PLRX) reporting earnings?
Pliant Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Pliant Therapeutics (PLRX) going to split?
There is no upcoming split for Pliant Therapeutics.
What sector and industry does Pliant Therapeutics (PLRX) operate in?
Pliant Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Pliant Therapeutics Stock (NASDAQ:PLRX), Quotes and News Summary
Pliant Therapeutics Stock (NASDAQ: PLRX) stock price, news, charts, stock research, profile.
| Open16.550 | Close- |
| Vol / Avg.155.414K / 686.019K | Mkt Cap1.007B |
| Day Range16.510 - 17.010 | 52 Wk Range14.470 - 36.640 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.710 | -0.700 | 0.0100 | ||||
| REV | 880.000K | 248.000K | -632.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-27 | HC Wainwright & Co. | Ed Arce | Maintains | BuyBuy | Raises | 50.00 | 52.00 |
| 2023-09-27 | Needham | Joseph Stringer | Reiterates | BuyBuy | Maintains | - | 45.00 |
| 2023-09-15 | Needham | Joseph Stringer | Reiterates | BuyBuy | Maintains | - | 45.00 |
| 2023-08-29 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 50.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PLRX | Pliant Therapeutics | 2.62% | 1B |
| GHRS | GH Research | -1.62% | 538.4M |
| SUPN | Supernus Pharmaceuticals | -1.39% | 1.5B |
| VRNA | Verona Pharma | -0.18% | 1.3B |
| WVE | WAVE Life Sciences | -3.83% | 546.4M |
How do I buy Pliant Therapeutics (PLRX) stock?
You can purchase shares of Pliant Therapeutics (NASDAQ: PLRX) through any online brokerage.
Who are Pliant Therapeutics's (PLRX) competitors?
Other companies in Pliant Therapeutics’s space includes: GH Research (NASDAQ:GHRS), Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE) and CymaBay Therapeutics (NASDAQ:CBAY).
What is the target price for Pliant Therapeutics (PLRX) stock?
The latest price target for Pliant Therapeutics (NASDAQ: PLRX) was reported by HC Wainwright & Co. on Wednesday, September 27, 2023. The analyst firm set a price target for 52.00 expecting PLRX to rise to within 12 months (a possible 208.97% upside). 35 analyst firms have reported ratings in the last year.
Current Stock Price for Pliant Therapeutics (PLRX)?
The stock price for Pliant Therapeutics (NASDAQ: PLRX) is $16.83 last updated Today at September 29, 2023 at 3:30 PM UTC.
Does Pliant Therapeutics (PLRX) pay a dividend?
There is no dividend information for Pliant Therapeutics.
When is Pliant Therapeutics (NASDAQ:PLRX) reporting earnings?
Pliant Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Pliant Therapeutics (PLRX) going to split?
There is no upcoming split for Pliant Therapeutics.
What sector and industry does Pliant Therapeutics (PLRX) operate in?
Pliant Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Pliant Therapeutics Stock (NASDAQ:PLRX), Quotes and News Summary
Pliant Therapeutics Stock (NASDAQ: PLRX) stock price, news, charts, stock research, profile.
| Open16.550 | Close- |
| Vol / Avg.155.414K / 686.019K | Mkt Cap1.007B |
| Day Range16.510 - 17.010 | 52 Wk Range14.470 - 36.640 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.710 | -0.700 | 0.0100 | ||||
| REV | 880.000K | 248.000K | -632.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-27 | HC Wainwright & Co. | Ed Arce | Maintains | BuyBuy | Raises | 50.00 | 52.00 |
| 2023-09-27 | Needham | Joseph Stringer | Reiterates | BuyBuy | Maintains | - | 45.00 |
| 2023-09-15 | Needham | Joseph Stringer | Reiterates | BuyBuy | Maintains | - | 45.00 |
| 2023-08-29 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 50.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PLRX | Pliant Therapeutics | 2.62% | 1B |
| GHRS | GH Research | -1.62% | 538.4M |
| SUPN | Supernus Pharmaceuticals | -1.39% | 1.5B |
| VRNA | Verona Pharma | -0.18% | 1.3B |
| WVE | WAVE Life Sciences | -3.83% | 546.4M |
How do I buy Pliant Therapeutics (PLRX) stock?
You can purchase shares of Pliant Therapeutics (NASDAQ: PLRX) through any online brokerage.
Who are Pliant Therapeutics's (PLRX) competitors?
Other companies in Pliant Therapeutics’s space includes: GH Research (NASDAQ:GHRS), Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE) and CymaBay Therapeutics (NASDAQ:CBAY).
What is the target price for Pliant Therapeutics (PLRX) stock?
The latest price target for Pliant Therapeutics (NASDAQ: PLRX) was reported by HC Wainwright & Co. on Wednesday, September 27, 2023. The analyst firm set a price target for 52.00 expecting PLRX to rise to within 12 months (a possible 208.97% upside). 35 analyst firms have reported ratings in the last year.
Current Stock Price for Pliant Therapeutics (PLRX)?
The stock price for Pliant Therapeutics (NASDAQ: PLRX) is $16.83 last updated Today at September 29, 2023 at 3:30 PM UTC.
Does Pliant Therapeutics (PLRX) pay a dividend?
There is no dividend information for Pliant Therapeutics.
When is Pliant Therapeutics (NASDAQ:PLRX) reporting earnings?
Pliant Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Pliant Therapeutics (PLRX) going to split?
There is no upcoming split for Pliant Therapeutics.
What sector and industry does Pliant Therapeutics (PLRX) operate in?
Pliant Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Pliant Therapeutics Stock (NASDAQ:PLRX), Quotes and News Summary
Pliant Therapeutics Stock (NASDAQ: PLRX) stock price, news, charts, stock research, profile.
| Open16.550 | Close- |
| Vol / Avg.155.414K / 686.019K | Mkt Cap1.007B |
| Day Range16.510 - 17.010 | 52 Wk Range14.470 - 36.640 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.710 | -0.700 | 0.0100 | ||||
| REV | 880.000K | 248.000K | -632.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-27 | HC Wainwright & Co. | Ed Arce | Maintains | BuyBuy | Raises | 50.00 | 52.00 |
| 2023-09-27 | Needham | Joseph Stringer | Reiterates | BuyBuy | Maintains | - | 45.00 |
| 2023-09-15 | Needham | Joseph Stringer | Reiterates | BuyBuy | Maintains | - | 45.00 |
| 2023-08-29 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 50.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PLRX | Pliant Therapeutics | 2.62% | 1B |
| GHRS | GH Research | -1.62% | 538.4M |
| SUPN | Supernus Pharmaceuticals | -1.39% | 1.5B |
| VRNA | Verona Pharma | -0.18% | 1.3B |
| WVE | WAVE Life Sciences | -3.83% | 546.4M |
How do I buy Pliant Therapeutics (PLRX) stock?
You can purchase shares of Pliant Therapeutics (NASDAQ: PLRX) through any online brokerage.
Who are Pliant Therapeutics's (PLRX) competitors?
Other companies in Pliant Therapeutics’s space includes: GH Research (NASDAQ:GHRS), Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE) and CymaBay Therapeutics (NASDAQ:CBAY).
What is the target price for Pliant Therapeutics (PLRX) stock?
The latest price target for Pliant Therapeutics (NASDAQ: PLRX) was reported by HC Wainwright & Co. on Wednesday, September 27, 2023. The analyst firm set a price target for 52.00 expecting PLRX to rise to within 12 months (a possible 208.97% upside). 35 analyst firms have reported ratings in the last year.
Current Stock Price for Pliant Therapeutics (PLRX)?
The stock price for Pliant Therapeutics (NASDAQ: PLRX) is $16.83 last updated Today at September 29, 2023 at 3:30 PM UTC.
Does Pliant Therapeutics (PLRX) pay a dividend?
There is no dividend information for Pliant Therapeutics.
When is Pliant Therapeutics (NASDAQ:PLRX) reporting earnings?
Pliant Therapeutics’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Pliant Therapeutics (PLRX) going to split?
There is no upcoming split for Pliant Therapeutics.
What sector and industry does Pliant Therapeutics (PLRX) operate in?
Pliant Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.